President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.The drugs are ...

PFE targets a catalyst-rich 2026 with pivotal obesity and oncology studies, key data readouts, and regulatory decisions across its pipeline.

President Trump has successfully negotiated a groundbreaking deal to include obesity drugs under Medicare coverage, marking a significant shift in healthcare policy. This agreement, announced on ...

Pfizer has confirmed another push into the obesity market in the form of a licencing deal worth up to approximately $2bn with Shanghai Fosun Pharmaceutical subsidiary YaoPharma. The big pharma company ...

AstraZeneca said it entered into a collaboration agreement with China's CSPC Pharmaceuticals to gain rights to a portfolio of early-stage experimental obesity and diabetes drugs, in a deal potentially ...

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy ...